Diabetes in Night Owls; 'Paradigm-Shifting' Drugs; Transgender Trials Unethical?

— News and commentary from the endocrinology world

MedicalToday
Endo Break over a computer rendering of a man with illustrated body organs.

Compared with women who are early birds, of developing diabetes, after taking into account lifestyle and sociodemographic factors. (Annals of Internal Medicine)

"Although numerous public health strategies geared toward reducing or have been implemented, these have had limited success overall," wrote researchers in a perspective on considering pediatric obesity a U.S. public health emergency. (Pediatrics)

A randomized trial showed that kids ages 4 to 6 had better weight trajectories over time if involved in an . (International Journal of Obesity)

Over 75% of U.S. physicians said are "paradigm-shifting" for weight loss, but few were satisfied with cost and insurance coverage, according to a new survey. (InCrowd)

There's a renewed push to get the government to and active-duty service members. (Axios)

Genetic mutations in the GLP-1 receptor likely modify the . (Nature Metabolism)

are ethically problematic, researchers say. (STAT)

Exposures to certain phenols, parabens, and per- and poly-fluoroalkyl substances were linked with increased odds of previous . (Journal of Exposure Science & Environmental Epidemiology)

Artificial intelligence and machine learning provided a high diagnostic and classification performance in (PCOS). (Frontiers in Endocrinology)

And in related news, may help reduce testosterone levels in women with PCOS. (Journal of the Endocrine Society)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.